Partner news
News
Other news
4 Ways Johnson & Johnson Advanced Much-Needed Healthcare Innovations Amid the Pandemic
Read full storyOther news
Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines
Read full storyPartner news
Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform
Read full storyPartner news
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
Read full storyOther news
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
Read full storyOther news
XWPharma Names Michael M. Morrissey, PhD to Board of Directors
Read full storyPartner news
Australian National University Announces Research Project with Janssen to Help Develop New Methods for Measuring and Monitoring Type 1 Diabetes
Read full storyPartner news
Symvivo Corporation Announces Research Agreement with Janssen to Offer Novel Approach to Therapeutic Protein Delivery
Read full storyPartner news
CHO Plus Announces Research Collaboration Agreement with Janssen to Improve Manufacturing of Therapeutic Proteins
Read full storyPartner news
UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease
Read full storyOther news
Big Data Institute announces collaboration with Janssen to advance understanding of human genetic signatures
Read full storyPartner news
Koa Health to collaborate with Janssen: Official press release
Read full storyOther news
Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot Program
Read full storyIn the media